Grove Collaborative Holdings Inc (GROV)
1.61
+0.02
(+1.26%)
USD |
NYSE |
May 31, 16:00
1.63
+0.02
(+1.24%)
Pre-Market: 20:00
Grove Collaborative Holdings Research and Development Expense (Quarterly): 3.626M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.626M |
| December 31, 2023 | 4.555M |
| September 30, 2023 | 3.578M |
| June 30, 2023 | 4.052M |
| March 31, 2023 | 4.216M |
| December 31, 2022 | 4.576M |
| Date | Value |
|---|---|
| September 30, 2022 | 5.765M |
| June 30, 2022 | 5.922M |
| March 31, 2022 | 6.24M |
| December 31, 2021 | 6.972M |
| September 30, 2021 | 5.586M |
| June 30, 2021 | 5.688M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.578M
Minimum
Sep 2023
6.972M
Maximum
Dec 2021
5.065M
Average
5.081M
Median
Research and Development Expense (Quarterly) Benchmarks
| The Beauty Health Co | 2.807M |
| Sentient Brands Holdings Inc | -- |
| Hims & Hers Health Inc | 15.32M |
| European Wax Center Inc | -- |
| Kenvue Inc | -- |